Nomax Therapeutics has filed a notice of an exempt offering of securities to raise $10,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Nomax Therapeutics is raising $10,000,000.00 in new funding. Sources indicate that as part of senior management President, Max Temnik played a key role in securing…